BMY logo

Bristol-Myers Squibb (BMY) Net income

annual net income:

-$8.95B-$16.97B(-211.50%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY annual net profit is -$8.95 billion, with the most recent change of -$16.97 billion (-211.50%) on December 1, 2024.
  • During the last 3 years, BMY annual net income has fallen by -$15.94 billion (-227.94%).
  • BMY annual net income is now -184.32% below its all-time high of $10.61 billion, reached on December 31, 2009.

Performance

BMY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly net income:

$72.00M-$1.14B(-94.05%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY quarterly net profit is $72.00 million, with the most recent change of -$1.14 billion (-94.05%) on December 1, 2024.
  • Over the past year, BMY quarterly net income has dropped by -$1.69 billion (-95.91%).
  • BMY quarterly net income is now -99.10% below its all-time high of $8.03 billion, reached on December 31, 2009.

Performance

BMY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM net income:

-$8.95B-$1.69B(-23.28%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY TTM net profit is -$8.95 billion, with the most recent change of -$1.69 billion (-23.28%) on December 1, 2024.
  • Over the past year, BMY TTM net income has dropped by -$16.97 billion (-211.50%).
  • BMY TTM net income is now -183.49% below its all-time high of $10.72 billion, reached on March 31, 2010.

Performance

BMY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BMY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-211.5%-95.9%-211.5%
3 y3 years-227.9%-95.9%-211.5%
5 y5 years-360.2%-95.9%-211.5%

BMY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-211.5%at low-96.8%+100.6%-208.0%at low
5 y5-year-211.5%+0.7%-97.0%+100.6%-208.0%+0.7%
alltimeall time-184.3%+0.7%-99.1%+100.6%-183.5%+0.7%

Bristol-Myers Squibb Net income History

DateAnnualQuarterlyTTM
Dec 2024
-$8.95B(-211.5%)
$72.00M(-94.1%)
-$8.95B(+23.3%)
Sep 2024
-
$1.21B(-27.9%)
-$7.26B(+11.0%)
Jun 2024
-
$1.68B(-114.1%)
-$6.54B(+6.4%)
Mar 2024
-
-$11.91B(-776.0%)
-$6.15B(-176.6%)
Dec 2023
$8.03B(+26.8%)
$1.76B(-8.6%)
$8.03B(-3.1%)
Sep 2023
-
$1.93B(-7.0%)
$8.29B(+4.0%)
Jun 2023
-
$2.07B(-8.4%)
$7.96B(+8.9%)
Mar 2023
-
$2.26B(+11.9%)
$7.31B(+15.6%)
Dec 2022
$6.33B(-9.5%)
$2.02B(+25.9%)
$6.33B(-5.2%)
Sep 2022
-
$1.61B(+13.0%)
$6.68B(+0.9%)
Jun 2022
-
$1.42B(+11.2%)
$6.62B(+5.9%)
Mar 2022
-
$1.28B(-46.1%)
$6.25B(-10.6%)
Dec 2021
$6.99B(-177.6%)
$2.37B(+53.4%)
$6.99B(-229.4%)
Sep 2021
-
$1.55B(+46.5%)
-$5.41B(+6.4%)
Jun 2021
-
$1.05B(-47.8%)
-$5.08B(-18.3%)
Mar 2021
-
$2.02B(-120.2%)
-$6.22B(-31.0%)
Dec 2020
-$9.02B(-362.1%)
-$10.03B(-635.6%)
-$9.02B(>+9900.0%)
Sep 2020
-
$1.87B(-2302.4%)
-$44.00M(-92.2%)
Jun 2020
-
-$85.00M(-89.0%)
-$563.00M(-159.0%)
Mar 2020
-
-$775.00M(-26.6%)
$954.00M(-72.3%)
Dec 2019
$3.44B(-30.1%)
-$1.06B(-178.0%)
$3.44B(-39.2%)
Sep 2019
-
$1.35B(-5.5%)
$5.66B(-8.8%)
Jun 2019
-
$1.43B(-16.3%)
$6.20B(+20.6%)
Mar 2019
-
$1.71B(+47.4%)
$5.14B(+4.6%)
Dec 2018
$4.92B(+388.6%)
$1.16B(-39.0%)
$4.92B(+243.6%)
Sep 2018
-
$1.90B(+409.7%)
$1.43B(+280.9%)
Jun 2018
-
$373.00M(-74.9%)
$376.00M(-59.1%)
Mar 2018
-
$1.49B(-163.8%)
$919.00M(-8.7%)
Dec 2017
$1.01B(-77.4%)
-$2.33B(-375.5%)
$1.01B(-76.2%)
Sep 2017
-
$845.00M(-7.8%)
$4.23B(-7.8%)
Jun 2017
-
$916.00M(-41.8%)
$4.59B(-5.2%)
Mar 2017
-
$1.57B(+76.1%)
$4.84B(+8.5%)
Dec 2016
$4.46B(+184.8%)
$894.00M(-25.6%)
$4.46B(+32.4%)
Sep 2016
-
$1.20B(+3.1%)
$3.37B(+17.3%)
Jun 2016
-
$1.17B(-2.4%)
$2.87B(+82.3%)
Mar 2016
-
$1.20B(-706.6%)
$1.57B(+0.6%)
Dec 2015
$1.56B(-21.9%)
-$197.00M(-127.9%)
$1.56B(-11.8%)
Sep 2015
-
$706.00M(-643.1%)
$1.77B(-0.8%)
Jun 2015
-
-$130.00M(-111.0%)
$1.79B(-20.6%)
Mar 2015
-
$1.19B(+9023.1%)
$2.25B(+12.4%)
Dec 2014
$2.00B(-21.8%)
$13.00M(-98.2%)
$2.00B(-26.2%)
Sep 2014
-
$721.00M(+116.5%)
$2.72B(+1.1%)
Jun 2014
-
$333.00M(-64.5%)
$2.69B(-7.0%)
Mar 2014
-
$937.00M(+29.1%)
$2.89B(+12.8%)
Dec 2013
$2.56B(+30.8%)
$726.00M(+4.9%)
$2.56B(-7.2%)
Sep 2013
-
$692.00M(+29.1%)
$2.76B(+103.2%)
Jun 2013
-
$536.00M(-12.0%)
$1.36B(-7.4%)
Mar 2013
-
$609.00M(-34.2%)
$1.47B(-25.1%)
Dec 2012
$1.96B(-47.2%)
$925.00M(-230.1%)
$1.96B(+3.9%)
Sep 2012
-
-$711.00M(-210.2%)
$1.89B(-47.1%)
Jun 2012
-
$645.00M(-41.4%)
$3.57B(-6.7%)
Mar 2012
-
$1.10B(+29.2%)
$3.82B(+3.1%)
Dec 2011
$3.71B(+19.6%)
$852.00M(-12.1%)
$3.71B(+11.0%)
Sep 2011
-
$969.00M(+7.4%)
$3.34B(+0.6%)
Jun 2011
-
$902.00M(-8.5%)
$3.32B(-0.7%)
Mar 2011
-
$986.00M(+104.1%)
$3.35B(+7.8%)
Dec 2010
$3.10B(-70.8%)
$483.00M(-49.1%)
$3.10B(-70.9%)
Sep 2010
-
$949.00M(+2.4%)
$10.64B(-0.2%)
Jun 2010
-
$927.00M(+24.8%)
$10.66B(-0.5%)
Mar 2010
-
$743.00M(-90.7%)
$10.72B(+1.0%)
Dec 2009
$10.61B(+102.2%)
$8.03B(+730.7%)
$10.61B(+177.0%)
Sep 2009
-
$966.00M(-1.7%)
$3.83B(-29.6%)
Jun 2009
-
$983.00M(+54.1%)
$5.44B(+4.2%)
Mar 2009
-
$638.00M(-48.7%)
$5.22B(-0.4%)
Dec 2008
$5.25B(+142.4%)
$1.24B(-51.7%)
$5.25B(+34.1%)
Sep 2008
-
$2.58B(+237.4%)
$3.91B(+78.4%)
Jun 2008
-
$764.00M(+15.6%)
$2.19B(+2.7%)
Mar 2008
-
$661.00M(-842.7%)
$2.14B(-1.3%)
Dec 2007
$2.17B(+36.6%)
-$89.00M(-110.4%)
$2.17B(+2.1%)
Sep 2007
-
$858.00M(+21.5%)
$2.12B(+32.5%)
Jun 2007
-
$706.00M(+2.3%)
$1.60B(+2.5%)
Mar 2007
-
$690.00M(-614.9%)
$1.56B(-1.5%)
Dec 2006
$1.58B(-47.2%)
-$134.00M(-139.6%)
$1.58B(-28.5%)
Sep 2006
-
$338.00M(-49.3%)
$2.22B(-22.0%)
Jun 2006
-
$667.00M(-6.6%)
$2.84B(-10.6%)
Mar 2006
-
$714.00M(+43.1%)
$3.18B(+6.0%)
DateAnnualQuarterlyTTM
Dec 2005
$3.00B(+25.6%)
$499.00M(-48.2%)
$3.00B(+13.6%)
Sep 2005
-
$964.00M(-4.0%)
$2.64B(+8.5%)
Jun 2005
-
$1.00B(+88.4%)
$2.43B(+24.4%)
Mar 2005
-
$533.00M(+283.5%)
$1.96B(-18.0%)
Dec 2004
$2.39B(-23.1%)
$139.00M(-81.7%)
$2.39B(-13.3%)
Sep 2004
-
$758.00M(+43.8%)
$2.75B(-5.1%)
Jun 2004
-
$527.00M(-45.3%)
$2.90B(-11.4%)
Mar 2004
-
$964.00M(+90.5%)
$3.28B(+5.5%)
Dec 2003
$3.11B(+45.3%)
$506.00M(-44.2%)
$3.11B(+2.0%)
Sep 2003
-
$906.00M(+0.4%)
$3.04B(+22.0%)
Jun 2003
-
$902.00M(+13.9%)
$2.50B(+20.4%)
Mar 2003
-
$792.00M(+78.0%)
$2.07B(-3.0%)
Dec 2002
$2.14B(-55.8%)
$445.00M(+24.6%)
$2.14B(-28.2%)
Sep 2002
-
$357.00M(-25.5%)
$2.98B(-21.8%)
Jun 2002
-
$479.00M(-44.0%)
$3.81B(-15.9%)
Mar 2002
-
$856.00M(-33.3%)
$4.53B(-9.6%)
Dec 2001
$4.83B(+2.6%)
$1.28B(+8.2%)
$5.01B(+2.5%)
Sep 2001
-
$1.19B(-1.2%)
$4.89B(-1.0%)
Jun 2001
-
$1.20B(-10.1%)
$4.94B(+2.3%)
Mar 2001
-
$1.34B(+14.9%)
$4.83B(+2.4%)
Dec 2000
$4.71B(+13.1%)
$1.16B(-5.9%)
$4.71B(+2.4%)
Sep 2000
-
$1.24B(+13.3%)
$4.60B(+3.1%)
Jun 2000
-
$1.09B(-10.6%)
$4.46B(+3.2%)
Mar 2000
-
$1.22B(+16.1%)
$4.32B(+3.7%)
Dec 1999
$4.17B(+32.7%)
$1.05B(-4.1%)
$4.17B(+18.1%)
Sep 1999
-
$1.10B(+15.2%)
$3.53B(+3.9%)
Jun 1999
-
$952.00M(-10.7%)
$3.40B(+3.6%)
Mar 1999
-
$1.07B(+158.1%)
$3.28B(+4.4%)
Dec 1998
$3.14B(-2.0%)
$413.00M(-57.2%)
$3.14B(-11.0%)
Sep 1998
-
$966.00M(+15.7%)
$3.53B(+3.2%)
Jun 1998
-
$835.00M(-9.9%)
$3.42B(+2.9%)
Mar 1998
-
$927.00M(+15.6%)
$3.32B(+3.7%)
Dec 1997
$3.21B(+12.5%)
$802.00M(-6.2%)
$3.21B(+2.8%)
Sep 1997
-
$855.00M(+15.9%)
$3.12B(+3.4%)
Jun 1997
-
$738.00M(-8.9%)
$3.02B(+2.8%)
Mar 1997
-
$810.00M(+13.1%)
$2.93B(+2.9%)
Dec 1996
$2.85B(+57.3%)
$716.00M(-4.9%)
$2.85B(+43.1%)
Sep 1996
-
$753.00M(+15.0%)
$1.99B(+3.3%)
Jun 1996
-
$655.00M(-9.8%)
$1.93B(+2.5%)
Mar 1996
-
$726.00M(-611.3%)
$1.88B(+3.8%)
Dec 1995
$1.81B(-1.6%)
-$142.00M(-120.6%)
$1.81B(-11.7%)
Sep 1995
-
$689.00M(+13.3%)
$2.05B(+3.4%)
Jun 1995
-
$608.00M(-7.5%)
$1.98B(+3.4%)
Mar 1995
-
$657.00M(+570.4%)
$1.92B(+4.1%)
Dec 1994
$1.84B(-6.0%)
$98.00M(-84.2%)
$1.84B(-7.9%)
Sep 1994
-
$621.00M(+14.6%)
$2.00B(+0.7%)
Jun 1994
-
$542.00M(-6.7%)
$1.99B(+1.1%)
Mar 1994
-
$581.00M(+127.0%)
$1.97B(+0.3%)
Dec 1993
$1.96B(-0.2%)
$256.00M(-57.9%)
$1.96B(-4.0%)
Sep 1993
-
$608.00M(+16.7%)
$2.04B(+0.9%)
Jun 1993
-
$521.00M(-9.4%)
$2.02B(+1.7%)
Mar 1993
-
$575.00M(+70.6%)
$1.99B(+1.4%)
Dec 1992
$1.96B(-4.6%)
$337.00M(-42.8%)
$1.96B(-8.1%)
Sep 1992
-
$589.00M(+20.7%)
$2.13B(+1.2%)
Jun 1992
-
$488.00M(-10.9%)
$2.11B(-0.1%)
Mar 1992
-
$548.00M(+7.5%)
$2.11B(+2.7%)
Dec 1991
$2.06B(+17.6%)
$510.00M(-9.4%)
$2.06B(+4.3%)
Sep 1991
-
$563.00M(+14.9%)
$1.97B(+3.5%)
Jun 1991
-
$490.00M(-0.6%)
$1.91B(+4.0%)
Mar 1991
-
$493.00M(+15.7%)
$1.83B(+4.8%)
Dec 1990
$1.75B(+134.0%)
$426.00M(-14.1%)
$1.75B(+80.4%)
Sep 1990
-
$496.00M(+18.9%)
$969.00M(+9.6%)
Jun 1990
-
$417.00M(+2.0%)
$884.00M(+8.9%)
Mar 1990
-
$409.00M(-215.9%)
$812.00M(+8.7%)
Dec 1989
$747.00M(-40.4%)
-$353.00M(-185.9%)
$747.00M(-46.4%)
Sep 1989
-
$411.00M(+19.1%)
$1.39B(+4.2%)
Jun 1989
-
$345.00M(+0.3%)
$1.34B(+3.1%)
Mar 1989
-
$344.00M(+17.4%)
$1.30B(+3.4%)
Dec 1988
$1.25B(+17.4%)
$293.00M(-17.5%)
$1.25B(+2.1%)
Sep 1988
-
$355.00M(+16.4%)
$1.23B(+7.7%)
Jun 1988
-
$305.00M(+1.3%)
$1.14B(+3.4%)
Mar 1988
-
$301.00M(+12.7%)
$1.10B(+3.2%)
Dec 1987
$1.07B
$267.00M(0.0%)
$1.07B(+33.3%)
Sep 1987
-
$267.00M(0.0%)
$801.00M(+50.0%)
Jun 1987
-
$267.00M(0.0%)
$534.00M(+100.0%)
Mar 1987
-
$267.00M
$267.00M

FAQ

  • What is Bristol-Myers Squibb annual net profit?
  • What is the all time high annual net income for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual net income year-on-year change?
  • What is Bristol-Myers Squibb quarterly net profit?
  • What is the all time high quarterly net income for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly net income year-on-year change?
  • What is Bristol-Myers Squibb TTM net profit?
  • What is the all time high TTM net income for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM net income year-on-year change?

What is Bristol-Myers Squibb annual net profit?

The current annual net income of BMY is -$8.95B

What is the all time high annual net income for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual net profit is $10.61B

What is Bristol-Myers Squibb annual net income year-on-year change?

Over the past year, BMY annual net profit has changed by -$16.97B (-211.50%)

What is Bristol-Myers Squibb quarterly net profit?

The current quarterly net income of BMY is $72.00M

What is the all time high quarterly net income for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly net profit is $8.03B

What is Bristol-Myers Squibb quarterly net income year-on-year change?

Over the past year, BMY quarterly net profit has changed by -$1.69B (-95.91%)

What is Bristol-Myers Squibb TTM net profit?

The current TTM net income of BMY is -$8.95B

What is the all time high TTM net income for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM net profit is $10.72B

What is Bristol-Myers Squibb TTM net income year-on-year change?

Over the past year, BMY TTM net profit has changed by -$16.97B (-211.50%)
On this page